DUBLIN--(BUSINESS WIRE)--Nov. 25, 2013--
plc (NYSE: MNK), a global specialty pharmaceutical and global medical
imaging company, will present at the 25th Annual Piper
Jaffray Healthcare Conference in New York on Tuesday, December 3, 2013.
Mark Trudeau, President and Chief Executive Officer of Mallinckrodt,
will represent the company in a session scheduled to begin at 10:00 U.S.
Eastern Standard Time. The meeting will be held at The New York Palace.
For those individuals who choose to participate in the conference via
audio webcast, please access at: http://mallinckrodt.com/investor_relations.
A replay of the presentation will be available on the website for 14
days following the conclusion of the meeting.
Mallinckrodt is a global specialty pharmaceutical business that
develops, manufactures, markets and distributes specialty pharmaceutical
products and medical imaging agents. The company’s Specialty
Pharmaceuticals segment includes branded and generic drugs and active
pharmaceutical ingredients, and the Global Medical Imaging segment
includes contrast media and nuclear imaging agents. Mallinckrodt has
approximately 5,500 employees worldwide and commercial presence in
roughly 70 countries. The company’s 2013 revenue totaled $2.2 billion.
To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Source: Mallinckrodt plc
John Moten, Investor Relations, 314-654-6650
Phillips, Media Relations, 314-654-3263